Navigation Links
Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer

WALTHAM, Mass., Dec. 12, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company") announced today the appointment of Namal Nawana as its new Chief Operating Officer, effective December 30, 2012. Mr. Nawana comes to Alere from Johnson & Johnson, where he has spent 15 years in various leadership roles, spanning the fields of engineering, marketing, sales and general management, including in Canada, Europe, the United States and the Asia Pacific region. At Alere, Mr. Nawana will be responsible for all commercial, R&D and operational functions, globally.

Mr. Nawana's experience before and at Johnson & Johnson  has earned him a reputation as a strategist, an innovator and a global operations leader focused on scaling businesses profitably. Most recently, Mr. Nawana served as the Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company, responsible for, among other things, managing all operations globally. Prior to that, he was Area Vice President for Johnson & Johnson Medical's operations in Australia and New Zealand, Chairman of the DePuy Asia Pacific Franchise Council, General Manager for DePuy Australia and General Manager for Depuy Canada. Through these roles, Mr. Nawana demonstrated a consistent track record of delivering year over year results.  During this time, Mr. Nawana was responsible for the planning and integration of numerous significant business acquisitions, and he played a key role in integrating the multi-billion dollar Synthes acquisition.

"Namal's extensive experience driving improvement and change within a global medical device manufacturer on the scale of DePuy Synthes Spine, and in particular his experience leading complex business integrations, fits perfectly with Alere's needs as worldwide provider of healthcare solutions which has experienced extraordinary growth through acquisitions," said Ron Zwanziger, Alere's Chief Executive Officer. "Namal's appointment demonstrates our commitment to improving execution at all levels. Just as important, Namal's visionary leadership and expertise in operational integration will aid Alere in delivering products which not only provide reliable diagnostics but also incorporate connectivity technologies that put patients in touch with caregivers on a real-time basis."

Mr. Nawana holds an Honours Degree in Mechanical Engineering (1992), a Masters of Medical Science from the University of Adelaide in South Australia (1995), and a MBA from the Henley Business School in the United Kingdom (2000). Additionally, Mr. Nawana achieved Six Sigma Process Excellence Black Belt certification through Johnson and Johnson and also Chartered Professional Engineer qualifications from the Institution of Engineers Australia.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the expected offering and the use of proceeds. These statements reflect Alere's current views with respect to future events and are based on management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, risks associated with market and economic conditions. Alere undertakes no obligation to update any forward-looking statements contained herein.

About Alere Inc.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology, diabetes, oncology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit

SOURCE Alere Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
2. Alere Inc. Announces Offering of $450 Million of Senior Notes
3. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
4. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
5. River Vision Announces Completion of $17 million Series A Financing
6. Winner Medical Announces Closing of Going Private Transaction
7. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
8. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
9. Net Medical Xpress Announces Substantial Teleradiology Growth and Major New Opportunities in Diagnostic/Clinical Crossover Care
10. Maine Manufacturing, LLC Announces the Acquisition of Laboratory Filter and Membrane Business from GE
11. Xstelos Holdings Announces Dividend
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015 ... of the "Global Brain Monitoring Devices ... --> ) has announced ... Monitoring Devices Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 2015 , ... A simply groundbreaking television series, "Voices in America", which is ... an array of issues that are presently affecting Americans. Dedicated to providing the world ... is changing the subjects consumers focus on, one episode at a time. , ...
Breaking Medicine News(10 mins):